Depletion of intracellular calcium stores activates storeoperated calcium entry across the plasma membrane in many cells. STIM1, the putative calcium sensor in the endoplasmic reticulum, and the calcium release-activated calcium (CRAC) modulator CRACM1 (also known as Orai1) in the plasma membrane have recently been shown to be essential for controlling the store-operated CRAC current (I CRAC ) 1-4 . However, individual overexpression of either protein fails to significantly amplify I CRAC . Here, we show that STIM1 and CRACM1 interact functionally. Overexpression of both proteins greatly potentiates I CRAC , suggesting that STIM1 and CRACM1 mutually limit store-operated currents and that CRACM1 may be the long-sought CRAC channel.
. When Ca 2+ is depleted from intracellular stores, STIM1 translocates to vesicular structures (punctae) underneath the plasma membrane, where it is hypothesized to activate CRAC channels residing in the plasma membrane. A second protein, CRACM1, has recently been identified as essential for activating CRAC channels 3, 4 . This protein contains four transmembrane domains, is located in the plasma membrane and, therefore, may represent the CRAC channel itself, a subunit of the channel, or a regulatory molecule that couples to the channel. When overexpressed individually, neither STIM1 nor CRACM1 can significantly potentiate I CRAC [1] [2] [3] [4] . To address the potential interaction of STIM1 and CRACM1, both proteins were overexpressed individually, or in combination, in HEK293 and Jurkat T cells and the CRAC currents were measured in response to Ca , respectively 4 ( Fig. 1a, c) , with typical inwardly rectifying current-voltage (I/V) relationships 5, 10, 11 (Fig. 1b, d ). Consistent with previous work 1, 9 , overexpression of STIM1 alone caused a small-to-modest increase in I CRAC in HEK293 and Jurkat cells (Fig. 1a, c) .
CRACM1 overexpression alone did not affect the CRAC currents induced by store depletion in HEK293 cells (Fig. 1a, b) and caused a small reduction in I CRAC in Jurkat cells (Fig. 1c, d ). Unless simply due to a general effect of transfection or variability of I CRAC across preparations, this reduction may be due to some kind of dominant-negative effect. Taken together, the available data on CRACM1 and STIM1 suggest that the individually expressed proteins, although essential for I CRAC manifestation, cannot significantly amplify the current. This would indicate that these proteins are either not sufficient to generate large CRAC currents or that they are stoichiometrically linked and limit each others' ability to generate CRAC currents above normal. Therefore, we co-overexpressed both proteins in HEK293 cells (see Supplementary Information, Fig. S1 ) and assessed storeoperated currents by patch clamp.
The co-overexpression of STIM1 and CRACM1, in both HEK293 and Jurkat cells, is sufficient to generate enormous membrane currents of approximately 30 pA pF -1 on store depletion by Ins(1,4,5)P 3 ( Fig. 1e ). These currents are significantly larger than the corresponding native currents evoked by the same experimental protocol and amount to an approximately 60-fold increase in HEK293 cells and approximately tenfold in Jurkat cells. The currents exhibit a similar time course of activation (Fig. 1e ) and the same inwardly rectifying I/V relationship (Fig. 1f) , as the well-characterized CRAC current 5, 10 . It should be noted that the average current presented in the graph represents an underestimate, as it excludes cells in which I CRAC increased to well above 50-100 pA pF -1 . In these cells, the massive Ca 2+ influx presumably saturated the intracellular Ca 2+ chelator BAPTA (1,20bis(o-aminophenoxy) ethane-N,N,N',N'-tetraacetic acid), causing the current to inactivate 5, 10 (see Supplementary  Information, Fig. S2 ).
To further characterize these currents, some specific properties that are considered the hallmarks of native CRAC currents were assessed. We established that the current could be activated by other stimuli that cause store depletion. Passive store depletion by 10 mM BAPTA, in the absence of Ins(1,4,5)P 3 , also recruited CRAC-like currents (Fig. 2a) . These developed after a characteristic delay that is likely to represent the time required for Ca 2+ to leak out of the stores 5 . The cells were next perfused with a solution in which the Ca 2+ concentration was buffered to
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approximately 150 nM to avoid store depletion and this did prevent current activation (Fig. 2b ). Subsequent application of ionomycin to release Ca 2+ from intracellular stores, however, rapidly activated large currents that exhibited the same rectifying I/V as I CRAC (Fig. 2c) .
The current produced by STIM1-CRACM1 overexpression was as specific for Ca 2+ ions as I CRAC 5, 10 . Removal of extracellular Ca 2+ (nominally Ca 2+ -free), while retaining normal levels of Mg 2+ , inhibited the inward currents evoked by store depletion (Fig. 2d) . Another specific characteristic of I CRAC is that it can carry Ba 2+ and Sr 2+ currents, albeit at smaller levels than Ca 2+ (refs 5,11,12) . Ion substitution experiments in which 10 mM extracellular Ca 2+ was replaced by equimolar amounts of Ba
2+
and Sr 2+ resulted in a strong inhibition of the current and very limited steady-state permeation of these ions compared with Ca 2+ (Fig. 2e) . I CRAC can also carry monovalent cations, such as Na + , when removing all divalent ions from the extracellular solution and this transiently increases inward currents 10 . The large currents in STIM1-CRACM1 overexpressing cells showed the same behaviour (Fig. 2f) . Whether or not the current exhibited the pharmacological profile of I CRAC , which is known to be enhanced by low concentrations of 2-aminoethoxydiphenylborate (2-APB) and inhibited at higher doses 13, 14 , was also assessed. Treatment with 50 µM 2-APB, after an initial increase as 2-APB concentration built up, completely blocked the current. Although these properties of the 
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large CRAC currents are generally in excellent agreement with those of native I CRAC , it is noteworthy that Sr 2+ and Ba 2+ currents seem smaller than those described for native I CRAC (refs 5,11,12) . This may reflect a genuine, small Ba 2+ -and Sr 2+ -permeability of the CRAC channels in STIM1-CRACM1 overexpressing cells, and/or compromised channel function, as a consequence of the removal of extracellular Ca 2+ (ref. 15 ). This difference in divalent permeation may also hint at the possibility of species differences, or that additional proteins -possibly other members of the STIM or CRACM families -may participate in shaping native CRAC currents.
In summary, our data establish that the co-overexpression of STIM1 and CRACM1 greatly amplifies store-operated currents and that these currents possess most of the defining characteristics of I CRAC . This suggests that STIM1 and CRACM1 are entirely sufficient to control the magnitude of the CRAC current. As individual overexpression of either protein fails to augment I CRAC , we conclude that they mutually represent limiting factors for CRAC current manifestation, although in Jurkat cells there may be a surplus of CRACM1 compared with STIM1, as STIM1 overexpression can enhance I CRAC approximately twofold (Fig. 1c) . Although more complex interpretations are conceivable, the most parsimonious interpretation of the fact that additional CRACM1 overexpression can amplify I CRAC 10-60-fold (and in some cells well above 100-fold) would be that CRACM1 itself constitutes the CRAC channel. anti-stim anti-myc anti-myc anti-stim anti-stim Figure S1 : Western blot of combined overexpression of STIM1 and CRACM1. Over-expression of both STIM1 and CRACM1 proteins was confirmed by making whole cell lysates of the co-transfected HEK cells. Since both the proteins are tagged on the C-terminal end with myc and His tags, overexpressed proteins were immunoprecipitated using anti-myc monoclonal antibody, resolved on SDS-PAGE and immunoblotted using antiHis antibody. The co-transfected cells showed the expected 84 KDa band corresponding to STIM1 and a nearly 37 KDa double band corresponding to CRACM1. The STIM1 alone and CRACM1 alone tranfected cells only showed the bands corresponding to STIM1 and CRACM1 respectively. Untransfected control cells did not show any bands corresponding to these two proteins, demonstrating that the anti-His antibody is specifically binding to the overexpressed, tagged proteins. All the lanes had bands corresponding to the heavy and the light chain of the antibodies used for immunoprecipitations at around 25 and 50 KDa. The co-expression strategy is described in the methods section. 
